Moderna's Omicron-targeting COVID-19 vaccine gets approval in Taiwan
hapabapa


The Taiwan Food and Drug Administration approved Moderna's (NASDAQ:MRNA) Omicron-targeting COVID-19 vaccine as a booster shot for individuals 18 years of age and above, Reuters reported.
The agency approved the adapted vaccine following evaluation of the shot's efficacy and safety, and "urgent domestic public health needs," the Sept. 2 report added.

A day ago, the Omicron-targeting booster dose was approved in Canada, and it also received the U.S. CDC backing, after having getting clearance from the U.S. FDA earlier in the week.
Yesterday, the adapted vaccine also received a recommendation of approval from a panel of the European Medicines Agency.
The bivalent vaccine has already received clearance in the U.K., Switzerland and Australia.